exhibit 10. 82 explanatory note : [ * * * ] indicates the portion of this exhibit that has been omitted because it is both ( i ) not material and ( ii ) would be competitively harmful if publicly disclosed. explanatory note : [ * * * ] indicates the portion of this exhibit explanatory note : [ * * * ] indicates the portion of this exhibit that has been omitted because it is both ( i ) not material that has been omitted because it is both ( i ) not material and ( ii ) would be competitively harmful if publicly disclosed. and ( ii ) would be competitively harmful if publicly disclosed. and ( ii ) would be competitively harmful if publicly disclosed. pharmaceutics international, inc. services change order initiation date 2 / 28 / 2022 project number : 27aim01 change order number : 1 aim immunotech inc. contact : victoria scott, director of quality & regulatory affairs corporate address : 2117 sw highway 484 ocala, fl 34473 corporate phone # # # - # # # - # # # # corporate fax : 352 # # # - # # # - # # # # email : * * * @ * * * pii contact : luis molina, director, business management corporate address : 10819 gilroy road hunt valley, md 21031 corporate phone : # # # - # # # - # # # # email : * * * @ * * * change order title : manufacture placebo feasibility batch ; method transfer for in - process assay – ampligen sterile solution initiation date 2 / 28 / 2022 project number : 27aim01 change order number : 1 initiation date 2 / 28 / 2022 initiation date 2 / 28 / 2022 project number : 27aim01 project number : 27aim01 change order number : 1 change order number : 1 aim immunotech inc. contact : victoria scott, director of quality & regulatory affairs corporate address : 2117 sw highway 484 ocala, fl 34473 corporate phone # # # - # # # - # # # # corporate fax : 352 # # # - # # # - # # # # email : * * * @ * * * pii contact : luis molina, director, business management corporate address : 10819 gilroy road hunt valley, md 21031 corporate phone : # # # - # # # - # # #